These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5706740)

  • 21. An approach to the medical treatment of hypertension in the aged.
    Vidt DG
    Geriatrics; 1969 Apr; 24(4):120-9. PubMed ID: 5774576
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy.
    Zoccali C
    J Nephrol; 2002; 15(2):199-201. PubMed ID: 12018640
    [No Abstract]   [Full Text] [Related]  

  • 23. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
    Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
    Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
    [No Abstract]   [Full Text] [Related]  

  • 24. [Control of drug resistant arterial hypertension before the stage of terminal chronic kidney failure by a weekly session of hemofiltration].
    Elsener M; Di-Falco F; Vialtel P; Cordonnier D; Meftahi H; Denis MC
    Nouv Presse Med; 1979 Feb; 8(9):698-9. PubMed ID: 450686
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical considerations in the treatment of arterial hypertension.
    Finnerty FA
    Mod Concepts Cardiovasc Dis; 1973 Aug; 42(8):37-40. PubMed ID: 4784808
    [No Abstract]   [Full Text] [Related]  

  • 26. The evaluation and treatment of essential hypertension.
    Mendlowitz M
    Proc Rudolf Virchow Med Soc City N Y; 1979 Jun; 33():35-40. PubMed ID: 294592
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modes of intensive therapy for arterial hypertension in children with terminal chronic kidney failure].
    Sharipov AM
    Urologiia; 2002; (3):49-51. PubMed ID: 12180062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Features of hypotensive therapy in patients with chronic renal insufficiency].
    Glezer GA; Ratner NA; Charyev M
    Klin Med (Mosk); 1971 Oct; 49(10):110-6. PubMed ID: 5133132
    [No Abstract]   [Full Text] [Related]  

  • 29. Nutritional measurements ad urea kinetics to guide intradialytic hyperalimentation.
    Thunberg B; Jain VK; Patterson PG; Cestero RV; Swamy AP
    Proc Clin Dial Transplant Forum; 1980; 10():22-8. PubMed ID: 6810345
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypertension in patients with chronic renal disease].
    Laville M
    Rev Prat; 2004 Mar; 54(6):641-5. PubMed ID: 15222616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral artery disease: a cause of refractory hypertension after renal transplantation.
    Dourado R; Gonçalves Pde A; Almeida M; Weigert A; Bruges M; Gaspar A; Negrão AP; Machado D; Clemente B; Teles R; Machado FP; Silva A
    Rev Port Cardiol; 2008 Mar; 27(3):353-7. PubMed ID: 18551921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 33. Ambulatory blood pressure monitoring assessment of blood pressure control in hypertension associated with chronic renal failure.
    Morduchowicz G; Zabludowski J; Wittenberg C; Winkler J; Boner G
    Nephrol Dial Transplant; 1993; 8(10):1169-71. PubMed ID: 8272233
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials with CIBA 1507--Go, a new antihypertensive compound.
    Misra RC; Gupta SK; Chuttani HK
    J Assoc Physicians India; 1970 Dec; 18(12):979-82. PubMed ID: 5509035
    [No Abstract]   [Full Text] [Related]  

  • 35. Discontinuation of chronic haemodialysis after control of arterial hypertension; long term follow-up.
    Wauters JP; Brunner HR
    Proc Eur Dial Transplant Assoc; 1983; 19():182-7. PubMed ID: 6878232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension dispensary at a central hospital].
    Ström T
    Lakartidningen; 1973 Oct; 70(41):3589-90. PubMed ID: 4787893
    [No Abstract]   [Full Text] [Related]  

  • 37. Establishment of a Difficult Hypertension Clinic in Whangarei, New Zealand: the first 18 months.
    van der Merwe W
    N Z Med J; 2008 Nov; 121(1285):63-72. PubMed ID: 19079438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hypertension in Italian nephrology out-patient clinics: the THIN Study.
    Russo D; Andreucci M; De Blasio A; Frattolillo P; Andreucci VE
    Semin Nephrol; 2005 Nov; 25(6):431-4. PubMed ID: 16298268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients.
    Wong PN; Mak SK; Lo KY; Tong GM; Wong AK
    Singapore Med J; 2004 Nov; 45(11):520-4. PubMed ID: 15510323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.